DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

A Look at Genetic Linkage between Clozapine-induced Agranulocytosis, Malignant Hyperthermia, Neuroleptic Malignant Syndrome, and Statin-induced Myopathy

by Nitin Pothen, MD; Shveta Kansal, MD; Theodor Rais, MD; Stacy Doumas, MD; and Ramon Solhkhah, MD Dr. Pothen and Dr. Kansal are with Ocean Medical Center, Hackensack Meridian Health

Use of Brexanolone for Postpartum Depression

by Jonathan R. Scarff, MD Dr. Scarff is with the Behavioral Health Service Line, Kenner Army Health Clinic, in Fort Lee, Virginia. Funding: No funding was provided. Disclosures: Disclaimer: The

Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain—Part II

by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada Kasaraneni, MBBS; Christiane S. Hampe, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is with the Department of Defense and

Navigating the ADA: What Clinicians Need to Know—Part One

by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Vice President of Risk Management at Professional Risk Management Services in Arlington, Virginia. Funding: No funding was provided for the preparation

Editorial Message and Issue Highlights–Vol. 16, No. 9–10, September-October 2019

Dear Colleagues: Welcome to the September–October 2019 edition of Innovations in Clinical Neuroscience (ICNS). We start this issue with a study titled, “Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and